Development and Characterization of Trihexyphenidyl Orodispersible Minitablets: A Challenge to Fill the Therapeutic Gap in Neuropediatrics
<b>Background:</b> Trihexyphenidyl (THP) has been widely used for over three decades as pediatric pharmacotherapy in patients affected by segmental and generalized dystonia. In order to achieve effective and safe pharmacotherapy for this population, new formulations are needed. <b>...
Saved in:
| Main Authors: | Camila Olivera, Oriana Boscolo, Cecilia Dobrecky, Claudia A. Ortega, Laura S. Favier, Valeria A. Cianchino, Sabrina Flor, Silvia Lucangioli |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/17/1/5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Behavioral signature of trihexyphenidyl in the TOR1A (DYT1) knockin mouse model of dystonia
by: Ahmad Abdal Qader, et al.
Published: (2025-08-01) -
Development of Orodispersible Ibuprofen Tablets Based on a Polymer-drug Complex
by: V. R. Timergalieva, et al.
Published: (2022-09-01) -
FORMULATION AND EVALUATION OF ORODISPERSIBLE TABLETS OF PYRIMETHAMINE
by: Anam Talat, et al.
Published: (2025-08-01) -
THE USE OF MODERN COMBINED ADDITIVE AGENTS FOR DIRECTLY COMPRESSED ORODISPERSIBLE TABLETS
by: Z. M. Kozlova, et al.
Published: (2019-01-01) -
Protective role of coenzyme Q10 against trihexyphenidyl-induced pulmonary toxicity in Wistar rats
by: Joseph Gbenga Omole, et al.
Published: (2025-05-01)